Exact Mass: 475.2828256000001
Exact Mass Matches: 475.2828256000001
Found 500 metabolites which its exact mass value is equals to given mass value 475.2828256000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Netilmicin
C21H41N5O7 (475.30058360000004)
Netilmicin is a semisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. [PubChem] Netilmicin inhibits protein synthesis in susceptible organisms by binding to the bacterial 30S ribosomal subunit and interfering with mRNA binding and the acceptor tRNA site. The bactericidal effect of netilmiicin is not fully understood. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic
Marckine
Alangimarckine
A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 as well as a hydroxy group at position 9.
Ulipristal acetate
C30H37NO4 (475.27224420000005)
A 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
LysoPE(0:0/18:3(9Z,12Z,15Z))
C23H42NO7P (475.26987520000006)
LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/18:3(6Z,9Z,12Z))
C23H42NO7P (475.26987520000006)
LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(18:3(6Z,9Z,12Z)/0:0)
C23H42NO7P (475.26987520000006)
LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Hydrocortamate
C27H41NO6 (475.29337260000005)
Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
LysoPE(18:3(9Z,12Z,15Z)/0:0)
C23H42NO7P (475.26987520000006)
LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
N-Docosahexaenoyl phenylalanine
N-docosahexaenoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl phenylalanine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Z-Leu-leu-leu-al
C26H41N3O5 (475.30460560000006)
Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate
C26H41N3O5 (475.30460560000006)
Ulipristal acetate
C30H37NO4 (475.27224420000005)
Z-LLNle-CHO
C26H41N3O5 (475.30460560000006)
8-desmethyl-isomigrastatin|8-desmethylisomigrastatin
17-hydroxy-8-desmethoxy-isomigrastatin|17-hydroxy-8-desmethoxyisomigrastatin|9-hydroxy-8,9-dihydrolactidomycin
Glu Val Thr Lys
Thr Val Lys Glu
C27H41NO6_(7E)-11-Hydroxy-3-isobutyl-4,5,8,13,13-pentamethyl-3,3a,4,6a,9,10,11,11a,14a,15-decahydro-1H-[1,3]dioxolo[9,10]oxacyclododecino[2,3-d]isoindole-1,16(2H)-dione
C27H41NO6 (475.29337260000005)
LPE 18:3
C23H42NO7P (475.26987520000006)
Annotation level-3
Ala Met Arg Val
C19H37N7O5S (475.25767520000005)
Ala Met Val Arg
C19H37N7O5S (475.25767520000005)
Ala Arg Met Val
C19H37N7O5S (475.25767520000005)
Ala Arg Val Met
C19H37N7O5S (475.25767520000005)
Ala Val Met Arg
C19H37N7O5S (475.25767520000005)
Ala Val Arg Met
C19H37N7O5S (475.25767520000005)
Cys Ile Ile Lys
C21H41N5O5S (475.2828256000001)
Cys Ile Lys Ile
C21H41N5O5S (475.2828256000001)
Cys Ile Lys Leu
C21H41N5O5S (475.2828256000001)
Cys Ile Leu Lys
C21H41N5O5S (475.2828256000001)
Cys Lys Ile Ile
C21H41N5O5S (475.2828256000001)
Cys Lys Ile Leu
C21H41N5O5S (475.2828256000001)
Cys Lys Leu Ile
C21H41N5O5S (475.2828256000001)
Cys Lys Leu Leu
C21H41N5O5S (475.2828256000001)
Cys Leu Ile Lys
C21H41N5O5S (475.2828256000001)
Cys Leu Lys Ile
C21H41N5O5S (475.2828256000001)
Cys Leu Lys Leu
C21H41N5O5S (475.2828256000001)
Cys Leu Leu Lys
C21H41N5O5S (475.2828256000001)
Cys Arg Val Val
C19H37N7O5S (475.25767520000005)
Cys Val Arg Val
C19H37N7O5S (475.25767520000005)
Cys Val Val Arg
C19H37N7O5S (475.25767520000005)
Asp Ile Lys Thr
Asp Ile Thr Lys
Asp Lys Ile Thr
Asp Lys Leu Thr
Asp Lys Thr Ile
Asp Lys Thr Leu
Asp Leu Lys Thr
Asp Leu Thr Lys
Asp Thr Ile Lys
Asp Thr Lys Ile
Asp Thr Lys Leu
Asp Thr Leu Lys
Glu Ile Lys Ser
Glu Ile Ser Lys
Glu Lys Ile Ser
Glu Lys Leu Ser
Glu Lys Ser Ile
Glu Lys Ser Leu
Glu Lys Thr Val
Glu Lys Val Thr
Glu Leu Lys Ser
Glu Leu Ser Lys
Glu Ser Ile Lys
Glu Ser Lys Ile
Glu Ser Lys Leu
Glu Ser Leu Lys
Glu Thr Lys Val
Glu Thr Val Lys
Glu Val Lys Thr
Gly Ile Met Arg
C19H37N7O5S (475.25767520000005)
Gly Ile Arg Met
C19H37N7O5S (475.25767520000005)
Gly Leu Met Arg
C19H37N7O5S (475.25767520000005)
Gly Leu Arg Met
C19H37N7O5S (475.25767520000005)
Gly Met Ile Arg
C19H37N7O5S (475.25767520000005)
Gly Met Leu Arg
C19H37N7O5S (475.25767520000005)
Gly Met Arg Ile
C19H37N7O5S (475.25767520000005)
Gly Met Arg Leu
C19H37N7O5S (475.25767520000005)
Gly Arg Ile Met
C19H37N7O5S (475.25767520000005)
Gly Arg Leu Met
C19H37N7O5S (475.25767520000005)
Gly Arg Met Ile
C19H37N7O5S (475.25767520000005)
Gly Arg Met Leu
C19H37N7O5S (475.25767520000005)
Ile Cys Ile Lys
C21H41N5O5S (475.2828256000001)
Ile Cys Lys Ile
C21H41N5O5S (475.2828256000001)
Ile Cys Lys Leu
C21H41N5O5S (475.2828256000001)
Ile Cys Leu Lys
C21H41N5O5S (475.2828256000001)
Ile Asp Lys Thr
Ile Asp Thr Lys
Ile Glu Lys Ser
Ile Glu Ser Lys
Ile Gly Met Arg
C19H37N7O5S (475.25767520000005)
Ile Gly Arg Met
C19H37N7O5S (475.25767520000005)
Ile Ile Cys Lys
C21H41N5O5S (475.2828256000001)
Ile Ile Lys Cys
C21H41N5O5S (475.2828256000001)
Ile Lys Cys Ile
C21H41N5O5S (475.2828256000001)
Ile Lys Cys Leu
C21H41N5O5S (475.2828256000001)
Ile Lys Asp Thr
Ile Lys Glu Ser
Ile Lys Ile Cys
C21H41N5O5S (475.2828256000001)
Ile Lys Leu Cys
C21H41N5O5S (475.2828256000001)
Ile Lys Ser Glu
Ile Lys Thr Asp
Ile Leu Cys Lys
C21H41N5O5S (475.2828256000001)
Ile Leu Lys Cys
C21H41N5O5S (475.2828256000001)
Ile Met Gly Arg
C19H37N7O5S (475.25767520000005)
Ile Met Arg Gly
C19H37N7O5S (475.25767520000005)
Ile Arg Gly Met
C19H37N7O5S (475.25767520000005)
Ile Arg Met Gly
C19H37N7O5S (475.25767520000005)
Ile Arg Ser Thr
Ile Arg Thr Ser
Ile Ser Glu Lys
Ile Ser Lys Glu
Ile Ser Arg Thr
Ile Ser Thr Arg
Ile Thr Asp Lys
Ile Thr Lys Asp
Ile Thr Arg Ser
Ile Thr Ser Arg
Lys Cys Ile Ile
C21H41N5O5S (475.2828256000001)
Lys Cys Ile Leu
C21H41N5O5S (475.2828256000001)
Lys Cys Leu Ile
C21H41N5O5S (475.2828256000001)
Lys Cys Leu Leu
C21H41N5O5S (475.2828256000001)
Lys Asp Ile Thr
Lys Asp Leu Thr
Lys Asp Thr Ile
Lys Asp Thr Leu
Lys Glu Ile Ser
Lys Glu Leu Ser
Lys Glu Ser Ile
Lys Glu Ser Leu
Lys Glu Thr Val
Lys Glu Val Thr
Lys Ile Cys Ile
C21H41N5O5S (475.2828256000001)
Lys Ile Cys Leu
C21H41N5O5S (475.2828256000001)
Lys Ile Asp Thr
Lys Ile Glu Ser
Lys Ile Ile Cys
C21H41N5O5S (475.2828256000001)
Lys Ile Leu Cys
C21H41N5O5S (475.2828256000001)
Lys Ile Ser Glu
Lys Ile Thr Asp
Lys Lys Asn Ser
Lys Lys Ser Asn
Lys Leu Cys Ile
C21H41N5O5S (475.2828256000001)
Lys Leu Cys Leu
C21H41N5O5S (475.2828256000001)
Lys Leu Asp Thr
Lys Leu Glu Ser
Lys Leu Ile Cys
C21H41N5O5S (475.2828256000001)
Lys Leu Leu Cys
C21H41N5O5S (475.2828256000001)
Lys Leu Ser Glu
Lys Leu Thr Asp
Lys Met Val Val
C21H41N5O5S (475.2828256000001)
Lys Asn Lys Ser
Lys Asn Ser Lys
Lys Ser Glu Ile
Lys Ser Glu Leu
Lys Ser Ile Glu
Lys Ser Lys Asn
Lys Ser Leu Glu
Lys Ser Asn Lys
Lys Thr Asp Ile
Lys Thr Asp Leu
Lys Thr Glu Val
Lys Thr Ile Asp
Lys Thr Leu Asp
Lys Thr Val Glu
Lys Val Glu Thr
Lys Val Met Val
C21H41N5O5S (475.2828256000001)
Lys Val Thr Glu
Lys Val Val Met
C21H41N5O5S (475.2828256000001)
Leu Cys Ile Lys
C21H41N5O5S (475.2828256000001)
Leu Cys Lys Ile
C21H41N5O5S (475.2828256000001)
Leu Cys Lys Leu
C21H41N5O5S (475.2828256000001)
Leu Cys Leu Lys
C21H41N5O5S (475.2828256000001)
Leu Asp Lys Thr
Leu Asp Thr Lys
Leu Glu Lys Ser
Leu Glu Ser Lys
Leu Gly Met Arg
C19H37N7O5S (475.25767520000005)
Leu Gly Arg Met
C19H37N7O5S (475.25767520000005)
Leu Ile Cys Lys
C21H41N5O5S (475.2828256000001)
Leu Ile Lys Cys
C21H41N5O5S (475.2828256000001)
Leu Lys Cys Ile
C21H41N5O5S (475.2828256000001)
Leu Lys Cys Leu
C21H41N5O5S (475.2828256000001)
Leu Lys Asp Thr
Leu Lys Glu Ser
Leu Lys Ile Cys
C21H41N5O5S (475.2828256000001)
Leu Lys Leu Cys
C21H41N5O5S (475.2828256000001)
Leu Lys Ser Glu
Leu Lys Thr Asp
Leu Leu Cys Lys
C21H41N5O5S (475.2828256000001)
Leu Leu Lys Cys
C21H41N5O5S (475.2828256000001)
Leu Met Gly Arg
C19H37N7O5S (475.25767520000005)
Leu Met Arg Gly
C19H37N7O5S (475.25767520000005)
Leu Arg Gly Met
C19H37N7O5S (475.25767520000005)
Leu Arg Met Gly
C19H37N7O5S (475.25767520000005)
Leu Arg Ser Thr
Leu Arg Thr Ser
Leu Ser Glu Lys
Leu Ser Lys Glu
Leu Ser Arg Thr
Leu Ser Thr Arg
Leu Thr Asp Lys
Leu Thr Lys Asp
Leu Thr Arg Ser
Leu Thr Ser Arg
Met Ala Arg Val
C19H37N7O5S (475.25767520000005)
Met Ala Val Arg
C19H37N7O5S (475.25767520000005)
Met Gly Ile Arg
C19H37N7O5S (475.25767520000005)
Met Gly Leu Arg
C19H37N7O5S (475.25767520000005)
Met Gly Arg Ile
C19H37N7O5S (475.25767520000005)
Met Gly Arg Leu
C19H37N7O5S (475.25767520000005)
Met Ile Gly Arg
C19H37N7O5S (475.25767520000005)
Met Ile Arg Gly
C19H37N7O5S (475.25767520000005)
Met Lys Val Val
C21H41N5O5S (475.2828256000001)
Met Leu Gly Arg
C19H37N7O5S (475.25767520000005)
Met Leu Arg Gly
C19H37N7O5S (475.25767520000005)
Met Arg Ala Val
C19H37N7O5S (475.25767520000005)
Met Arg Gly Ile
C19H37N7O5S (475.25767520000005)
Met Arg Gly Leu
C19H37N7O5S (475.25767520000005)
Met Arg Ile Gly
C19H37N7O5S (475.25767520000005)
Met Arg Leu Gly
C19H37N7O5S (475.25767520000005)
Met Arg Val Ala
C19H37N7O5S (475.25767520000005)
Met Val Ala Arg
C19H37N7O5S (475.25767520000005)
Met Val Lys Val
C21H41N5O5S (475.2828256000001)
Met Val Arg Ala
C19H37N7O5S (475.25767520000005)
Met Val Val Lys
C21H41N5O5S (475.2828256000001)
Asn Lys Lys Ser
Asn Lys Ser Lys
Asn Ser Lys Lys
Arg Ala Met Val
C19H37N7O5S (475.25767520000005)
Arg Ala Val Met
C19H37N7O5S (475.25767520000005)
Arg Cys Val Val
C19H37N7O5S (475.25767520000005)
Arg Gly Ile Met
C19H37N7O5S (475.25767520000005)
Arg Gly Leu Met
C19H37N7O5S (475.25767520000005)
Arg Gly Met Ile
C19H37N7O5S (475.25767520000005)
Arg Gly Met Leu
C19H37N7O5S (475.25767520000005)
Arg Ile Gly Met
C19H37N7O5S (475.25767520000005)
Arg Ile Met Gly
C19H37N7O5S (475.25767520000005)
Arg Ile Ser Thr
Arg Ile Thr Ser
Arg Leu Gly Met
C19H37N7O5S (475.25767520000005)
Arg Leu Met Gly
C19H37N7O5S (475.25767520000005)
Arg Leu Ser Thr
Arg Leu Thr Ser
Arg Met Ala Val
C19H37N7O5S (475.25767520000005)
Arg Met Gly Ile
C19H37N7O5S (475.25767520000005)
Arg Met Gly Leu
C19H37N7O5S (475.25767520000005)
Arg Met Ile Gly
C19H37N7O5S (475.25767520000005)
Arg Met Leu Gly
C19H37N7O5S (475.25767520000005)
Arg Met Val Ala
C19H37N7O5S (475.25767520000005)
Arg Ser Ile Thr
Arg Ser Leu Thr
Arg Ser Thr Ile
Arg Ser Thr Leu
Arg Thr Ile Ser
Arg Thr Leu Ser
Arg Thr Ser Ile
Arg Thr Ser Leu
Arg Thr Thr Val
Arg Thr Val Thr
Arg Val Ala Met
C19H37N7O5S (475.25767520000005)
Arg Val Cys Val
C19H37N7O5S (475.25767520000005)
Arg Val Met Ala
C19H37N7O5S (475.25767520000005)
Arg Val Thr Thr
Arg Val Val Cys
C19H37N7O5S (475.25767520000005)
Ser Glu Ile Lys
Ser Glu Lys Ile
Ser Glu Lys Leu
Ser Glu Leu Lys
Ser Ile Glu Lys
Ser Ile Lys Glu
Ser Ile Arg Thr
Ser Ile Thr Arg
Ser Lys Glu Ile
Ser Lys Glu Leu
Ser Lys Ile Glu
Ser Lys Lys Asn
Ser Lys Leu Glu
Ser Lys Asn Lys
Ser Leu Glu Lys
Ser Leu Lys Glu
Ser Leu Arg Thr
Ser Leu Thr Arg
Ser Asn Lys Lys
Ser Arg Ile Thr
Ser Arg Leu Thr
Ser Arg Thr Ile
Ser Arg Thr Leu
Ser Thr Ile Arg
Ser Thr Leu Arg
Ser Thr Arg Ile
Ser Thr Arg Leu
Thr Asp Ile Lys
Thr Asp Lys Ile
Thr Asp Lys Leu
Thr Asp Leu Lys
Thr Glu Lys Val
Thr Glu Val Lys
Thr Ile Asp Lys
Thr Ile Lys Asp
Thr Ile Arg Ser
Thr Ile Ser Arg
Thr Lys Asp Ile
Thr Lys Asp Leu
Thr Lys Glu Val
Thr Lys Ile Asp
Thr Lys Leu Asp
Thr Lys Val Glu
Thr Leu Asp Lys
Thr Leu Lys Asp
Thr Leu Arg Ser
Thr Leu Ser Arg
Thr Arg Ile Ser
Thr Arg Leu Ser
Thr Arg Ser Ile
Thr Arg Ser Leu
Thr Arg Thr Val
Thr Arg Val Thr
Thr Ser Ile Arg
Thr Ser Leu Arg
Thr Ser Arg Ile
Thr Ser Arg Leu
Thr Thr Arg Val
Thr Thr Val Arg
Thr Val Glu Lys
Thr Val Arg Thr
Thr Val Thr Arg
Val Ala Met Arg
C19H37N7O5S (475.25767520000005)
Val Ala Arg Met
C19H37N7O5S (475.25767520000005)
Val Cys Arg Val
C19H37N7O5S (475.25767520000005)
Val Cys Val Arg
C19H37N7O5S (475.25767520000005)
Val Glu Lys Thr
Val Glu Thr Lys
Val Lys Glu Thr
Val Lys Met Val
C21H41N5O5S (475.2828256000001)
Val Lys Thr Glu
Val Lys Val Met
C21H41N5O5S (475.2828256000001)
Val Met Ala Arg
C19H37N7O5S (475.25767520000005)
Val Met Lys Val
C21H41N5O5S (475.2828256000001)
Val Met Arg Ala
C19H37N7O5S (475.25767520000005)
Val Met Val Lys
C21H41N5O5S (475.2828256000001)
Val Arg Ala Met
C19H37N7O5S (475.25767520000005)
Val Arg Cys Val
C19H37N7O5S (475.25767520000005)
Val Arg Met Ala
C19H37N7O5S (475.25767520000005)
Val Arg Thr Thr
Val Arg Val Cys
C19H37N7O5S (475.25767520000005)
Val Thr Glu Lys
Val Thr Lys Glu
Val Thr Arg Thr
Val Thr Thr Arg
Val Val Cys Arg
C19H37N7O5S (475.25767520000005)
Val Val Lys Met
C21H41N5O5S (475.2828256000001)
Val Val Met Lys
C21H41N5O5S (475.2828256000001)
Val Val Arg Cys
C19H37N7O5S (475.25767520000005)
MG-132
C26H41N3O5 (475.30460560000006)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
(R)-MG132
C26H41N3O5 (475.30460560000006)
LPE(18:3)
C23H42NO7P (475.26987520000006)
PE(18:3(6Z,9Z,12Z)/0:0)
C23H42NO7P (475.26987520000006)
LysoPE(18:3/0:0)
C23H42NO7P (475.26987520000006)
hydrocortamate
C27H41NO6 (475.29337260000005)
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
icas#18
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from (10R)-10-hydroxyundecanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
icos#18
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from 11-hydroxyundecanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
1-[[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
C27H41NO6 (475.29337260000005)
2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester
triethanolammonium dodecylbenzene sulfonate
C24H45NO6S (475.29674300000005)
3-Pyridinemethanol, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-a-methyl-2,6-bis(1-methylethyl)-5-(1-penten-1-yl)-
Tolterodine tartrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tolterodine Tartrate (Kabi-2234; PNU-200583E) is a potent muscarinic receptor antagonist and shows selectivity for the urinary bladder over salivary glands in vivo.
1-HYDROXY-N-[4-(2,4-DI-TERT-PENTYLPHENOXY)BUTYL]-2-NAPHTHAMIDE
Z-Leu-Leu-Nle-aldehyde
C26H41N3O5 (475.30460560000006)
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators Z-LLNle-CHO (Z-Leu-Leu-Nle-CHO) is a γ-secretase inhibitor I. Z-LLNle-CHO induces caspase and ROS-dependent apoptosis by blocking the Akt-mediated pro-survival pathway. Z-LLNle-CHO can be used in cancer research, such as breast cancer and leukaemia[1][2].
2(3H)-Furanone, 5-hexyldihydro-4-methyl-, mixt. with 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride (1:1)
C28H42ClNO3 (475.28530520000004)
1-HYDROXY-N-(2-TETRADECYLOXYPHENYL)-2-NAPHTHALENECARBOXAMIDE
Propanamide, N-(2,6-dimethyl-4-((4-(methyl(2-phenylethyl)amino)-1-piperidinyl)carbonyl)phenyl)-, hydrochloride, hydrate (1:1:1)
11-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]undecanoic acid
(10R)-10-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]undecanoic acid
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadeca-6,9,12-trienoate
C23H42NO7P (475.26987520000006)
1-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine
C23H42NO7P (475.26987520000006)
(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
C21H41N5O7 (475.30058360000004)
Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate
C26H41N3O5 (475.30460560000006)
2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol (2R,3R)-2,3-dihydroxybutanedioic acid hydrate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents
1-(N-[2-(benzotriazol-1-yl)acetyl]-4-methoxyanilino)-N-cyclopentylcyclohexane-1-carboxamide
C27H33N5O3 (475.2583268000001)
N-hexanoylsphingosine 1-phosphate(2-)
C24H46NO6P-2 (475.30625860000004)
[(8S,11R,13S,14S,17S)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
C30H37NO4 (475.27224420000005)
N-[4-methyl-1-[[4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester
C26H41N3O5 (475.30460560000006)
N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
(8R,9R,10R)-10-(hydroxymethyl)-N-(4-methoxyphenyl)-9-[4-(4-methylpent-1-ynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(3-morpholin-4-ylpropyl)acetamide
2-[(3S,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(3R,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
2-[(3R,6aR,8R,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H33N5O3 (475.2583268000001)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C26H41N3O5 (475.30460560000006)
N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C26H41N3O5 (475.30460560000006)
2-[(3S,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(3S,6aS,8S,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide
[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C24H46NO6P (475.30625860000004)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]dec-4-ene-1-sulfonic acid
C24H45NO6S (475.29674300000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] acetate
C23H42NO7P (475.26987520000006)
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)dodeca-4,8-diene-1-sulfonic acid
C24H45NO6S (475.29674300000005)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]dodec-4-ene-1-sulfonic acid
C24H45NO6S (475.29674300000005)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]undec-4-ene-1-sulfonic acid
C24H45NO6S (475.29674300000005)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
C23H42NO7P (475.26987520000006)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate
C23H42NO7P (475.26987520000006)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
C23H42NO7P (475.26987520000006)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate
C23H42NO7P (475.26987520000006)
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Tubulosine
A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 and a hydroxy group at the 8 position.
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine
C23H42NO7P (475.26987520000006)
(1S,2S,3R,4S,6R)-4-amino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-6-(ethylamino)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside
C21H41N5O7 (475.30058360000004)
Benzyl n-[(2s)-4-methyl-1-[[(2r)-4-methyl-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate
C26H41N3O5 (475.30460560000006)
N-hexanoylsphingosine 1-phosphate(2-)
C24H46NO6P (475.30625860000004)
A ceramide 1-phosphate(2-) in which the ceramide N-acyl group is specified as hexanoyl; major species at pH 7.3.
PE(18:3)
C23H42NO7P (475.26987520000006)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(4e,8s,9s,10e,12s,13r,14s,16r)-8,14-dimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,10,18(22),19-hexaene-3,9,13,20-tetrol
C27H41NO6 (475.29337260000005)
4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
C27H41NO6 (475.29337260000005)
4-[(5s,6e)-7-[(2r,3s,4s,5s,6e,10e)-4,5-dihydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl]-5-methyl-4-oxooct-6-en-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
6-hydroxy-4-[(2r,5s,6e)-2-hydroxy-7-[(2r,3s,4r,6e,10e)-4-hydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl]-5-methyl-4-oxooct-6-en-1-yl]-4,5-dihydro-3h-pyridin-2-one
(2e,4e)-n-[5,6'-dihydroxy-6'-(2-oxopropyl)-3h-4',8'-dioxaspiro[furan-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
(1s,2s,3s,4s,5s,6r,8s,12s,13s,16r,19s,20r,21s)-4,6,19-trimethoxy-14,16-dimethyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docos-17-en-21-yl acetate
(1r,2r)-2-[(2s,4e,6z,8r,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclobutane-1-carboxylic acid
C27H41NO6 (475.29337260000005)
1-({3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
n-[(3s,4r,7r,8r,9s)-7-hexyl-4,9-dimethyl-8-[(2-methylpropanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl]benzenecarboximidic acid
n-[(2s,3r)-6-(aminomethyl)-2-{[(1r,2s,3s,4r,6s)-4,6-diamino-3-{[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-3,4-dihydro-2h-pyran-3-yl]carboximidic acid
(1r,2s)-2-[(2r,4e,6e,8r,9r,11r,13r,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]-1-methylcyclopropane-1-carboxylic acid
C27H41NO6 (475.29337260000005)
6-hydroxy-4-[2-hydroxy-7-(4-hydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl)-5-methyl-4-oxooct-6-en-1-yl]-4,5-dihydro-3h-pyridin-2-one
6-hydroxy-4-[(2r,5s,6e)-2-hydroxy-7-[(2r,3s,5s,6e,10e)-5-hydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl]-5-methyl-4-oxooct-6-en-1-yl]-4,5-dihydro-3h-pyridin-2-one
6-hydroxy-4-[2-hydroxy-7-(5-hydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl)-5-methyl-4-oxooct-6-en-1-yl]-4,5-dihydro-3h-pyridin-2-one
4-[7-(4,5-dihydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl)-5-methyl-4-oxooct-6-en-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
3-ethyl-9,10-dimethoxy-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-8-ol
n-[6-(aminomethyl)-2-[(4,6-diamino-3-{[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-5,6-dihydro-4h-pyran-3-yl]carboximidic acid
(1s)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
4-[(5s,6e)-7-[(2s,3s,4s,5s,6e,10e)-4,5-dihydroxy-3-methyl-12-oxo-1-oxacyclododeca-6,10-dien-2-yl]-5-methyl-4-oxooct-6-en-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
C27H41NO6 (475.29337260000005)
(4s,7r,8s,9s,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
C27H41NO6 (475.29337260000005)
2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl)-1-methylcyclopropane-1-carboxylic acid
C27H41NO6 (475.29337260000005)